Concepedia

Andrew M. Waters

AM

19

Publications

2K

Citations

16

H-Index

2010

Active since

Affiliations

University of North Carolina at Chapel Hill(Current)

Harvard University

George Mason University

Translational Genomics Research Institute

Broad Institute

Andrew M. Waters is an author at University of North Carolina at Chapel Hill specializing in tumor biology, medicine, and cancer research.

ORCID

Top concepts

Publications per year

2010–2024

19

Publications

19

Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer

Kirsten L. Bryant, Clint A. Stalnecker, Daniel Zeitouni et al. · Nature Medicine · 2019 · 695 citations

, , +9

Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy

Matthew Holderfield, Bianca J. Lee, Jingjing Jiang et al. · Nature · 2024 · 268 citations · Full text

Atypical KRASG12R Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer

G. Aaron Hobbs, Nicole M. Baker, Anne M. Miermont et al. · Cancer Discovery · 2019 · 210 citations · Full text

Differential Effector Engagement by Oncogenic KRAS

Tina L. Yuan, Arnaud Amzallag, Rachel Bagni et al. · Cell Reports · 2018 · 149 citations · Full text

Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i> Mutant Pancreatic Cancer

Craig M. Goodwin, Andrew M. Waters, Jennifer E. Klomp et al. · Cancer Research · 2022 · 144 citations · Full text

Rows per page

1–5 of 19